Defining a cure for type 1 diabetes: a call to action-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Defining a cure for type 1 diabetes: a call to action

Published:2021-09 Issue:9 Volume:9 Page:553-555
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Roep Bart O,Montero Enrique,van Tienhoven René,Atkinson Mark A,Schatz Desmond A,Mathieu Chantal

Funder

European Commission

Juvenile Diabetes Research Foundation International

Horizon 2020

Leona M. and Harry B. Helmsley Charitable Trust

Innovative Medicines Initiative

European Federation of Pharmaceutical Industries and Associations

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference10 articles.

1. 2016 presidential address: diabetes at 212°—confronting the invisible disease;Schatz;Diabetes Care,2016

2. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association;Insel;Diabetes Care,2015

3. The challenge of modulating β-cell autoimmunity in type 1 diabetes;Atkinson;Lancet Diabetes Endocrinol,2019

4. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?);Roep;Nat Rev Endocrinol,2021

5. Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes;Battaglia;Diabetes Care,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological function of type 1 regulatory cells and their role in type 1 diabetes;Heliyon;2024-09

2. Topical delivery of insulin using novel organogel formulations: An approach for the management of diabetic wounds;Burns;2024-06

3. PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration;International Immunopharmacology;2024-05

4. Time for changes in type 1 diabetes intervention trial designs;The Lancet Diabetes & Endocrinology;2023-11

5. The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas;Cell Metabolism;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3